Analyze Diet
Journal of equine veterinary science2024; 140; 105135; doi: 10.1016/j.jevs.2024.105135

Bacillus toyonensis amplifies the immunogenicity of an experimental recombinant tetanus vaccine in horses.

Abstract: Probiotic microorganisms can stimulate an immune response and increase the efficiency of vaccines. For example, Bacillus toyonensis is a nonpathogenic, Gram-positive bacterium that has been used as a probiotic in animal supplementation. It induces immunomodulatory effects and increases the vaccine response in several species. This study aimed to evaluate the effect of B. toyonensis supplementation on the modulation of the immune response in horses vaccinated with recombinant Clostridium tetani toxin. Twenty horses were vaccinated twice, with an interval of 21 days between doses, and equally divided into two groups: the first group was supplemented orally for 42 days with feed containing viable spores of B. toyonensis (1 × 10) mixed with molasses (40 ml), starting 7 days before the first vaccination; the second (control) group received only feed mixed with molasses, starting 7 days before the first vaccination. Serum samples were collected to evaluate the humoral immune response using an in-house indirect enzyme-linked immunosorbent assay (ELISA), and peripheral blood mononuclear cells (PBMCs) were collected to evaluate cytokine transcription (qPCR). For the specific IgG-anti-rTENT titer, the supplemented group had ELISA values that were four times higher than those of the control group (p < 0.05). The supplemented group also showed higher ELISA values for the IgGa and IgGT sub-isotypes compared to the control group. In PBMCs stimulated with B. toyonensis, relative cytokine transcription of the supplemented group showed 15-, 8-, 7-, and 6-fold increases for IL1, TNFα, IL10 and IL4, respectively. When stimulated with a vaccine antigen, the supplemented group showed 1.6-, 1.8-, and 0.5-fold increases in IL1, TNFα, and IL4, respectively, compared to the control group. Horses supplemented with B. toyonensis had a significantly improved vaccine immune response compared to those in the control group, which suggests a promising approach for improving vaccine efficacy with probiotics.
Publication Date: 2024-06-22 PubMed ID: 38914241DOI: 10.1016/j.jevs.2024.105135Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Overview

  • This study investigated how supplementing horses with the probiotic Bacillus toyonensis affects their immune response to a recombinant tetanus vaccine.
  • The results showed that horses receiving B. toyonensis had a stronger antibody response and increased immune cell activity compared to controls.

Introduction and Background

  • Probiotic microorganisms, like Bacillus toyonensis, can stimulate immune responses and potentially improve vaccine effectiveness.
  • Bacillus toyonensis is a nonpathogenic, Gram-positive bacterium used as a probiotic in animal feed that has demonstrated immunomodulatory effects across species.
  • The focus of this study was to test the impact of B. toyonensis supplementation on immune responses in horses vaccinated with a recombinant tetanus toxin from Clostridium tetani.

Study Design and Methodology

  • Twenty horses were divided into two equal groups (10 horses each):
    • Supplemented group: Fed daily with B. toyonensis spores mixed in molasses for 42 days, starting 7 days before the first vaccination.
    • Control group: Fed with molasses only (no probiotic), following the same timeline.
  • All horses received two doses of the recombinant tetanus vaccine, spaced 21 days apart.
  • Serum samples were collected to measure humoral immune responses using an in-house indirect ELISA for specific antibodies (IgG and its subtypes IgGa and IgGT) against the recombinant tetanus antigen.
  • Peripheral blood mononuclear cells (PBMCs) were extracted to assess cytokine gene expression via quantitative PCR (qPCR) after stimulation with either B. toyonensis or the vaccine antigen.

Key Findings on Antibody Responses

  • The group supplemented with B. toyonensis showed significantly higher antibody titers against the recombinant tetanus toxin:
    • ELISA values were four times greater in the supplemented group compared to controls (p < 0.05).
    • Higher levels of IgG sub-isotypes IgGa and IgGT were also observed in the supplemented horses, indicating a stronger and more diverse humoral response.

Immune Cell Cytokine Responses

  • PBMCs from supplemented horses displayed notable increases in cytokine mRNA transcription after stimulation with B. toyonensis:
    • IL1 increased by 15-fold, indicating heightened pro-inflammatory signaling.
    • TNFα increased 8-fold, supporting enhanced immune activation.
    • IL10 and IL4, involved in anti-inflammatory and helper T cell functions, increased 7- and 6-fold respectively.
  • When PBMCs were stimulated with the tetanus vaccine antigen, supplemented horses showed:
    • 1.6-fold increase in IL1 transcription.
    • 1.8-fold increase in TNFα transcription.
    • A slight decrease (0.5-fold) in IL4 transcription compared to controls.

Conclusions and Implications

  • Supplementation with B. toyonensis significantly enhanced both the antibody-mediated (humoral) and cytokine-mediated immune responses to an experimental recombinant tetanus vaccine in horses.
  • The probiotic appears to modulate immune cell activity, promoting a stronger response to vaccination.
  • This suggests that using B. toyonensis as a dietary supplement could be a promising strategy to improve vaccine efficacy in horses and potentially other animals.
  • Such findings support the growing interest in probiotics as immunomodulatory agents that can boost protective immunity during vaccination protocols.

Cite This Article

APA
Abreu MC, Conrad NL, Gonçalves VS, Leite FPL. (2024). Bacillus toyonensis amplifies the immunogenicity of an experimental recombinant tetanus vaccine in horses. J Equine Vet Sci, 140, 105135. https://doi.org/10.1016/j.jevs.2024.105135

Publication

ISSN: 0737-0806
NlmUniqueID: 8216840
Country: United States
Language: English
Volume: 140
Pages: 105135
PII: S0737-0806(24)00141-2

Researcher Affiliations

Abreu, Mayara Caetano
  • Departament of Veterinary Medicine, Federal University of Pelotas, UFPel, Capão do Leão, Rio Grande do Sul, Brazil.
Conrad, Neida Lucia
  • Center for Technological Development, Biotecnology, Federal University of Pelotas, UFPel, Capão do Leão, Rio Grande do Sul, Brazil.
Gonçalves, Vitória Sequeira
  • Center for Technological Development, Biotecnology, Federal University of Pelotas, UFPel, Capão do Leão, Rio Grande do Sul, Brazil.
Leite, Fábio Pereira Leivas
  • Departament of Veterinary Medicine, Federal University of Pelotas, UFPel, Capão do Leão, Rio Grande do Sul, Brazil; Center for Technological Development, Biotecnology, Federal University of Pelotas, UFPel, Capão do Leão, Rio Grande do Sul, Brazil. Electronic address: fleivasleite@gmail.com.

MeSH Terms

  • Animals
  • Horses / immunology
  • Bacillus / immunology
  • Probiotics / administration & dosage
  • Probiotics / pharmacology
  • Horse Diseases / prevention & control
  • Horse Diseases / immunology
  • Horse Diseases / microbiology
  • Tetanus / prevention & control
  • Tetanus / immunology
  • Tetanus Toxoid / immunology
  • Tetanus Toxoid / administration & dosage
  • Vaccines, Synthetic / immunology
  • Vaccines, Synthetic / administration & dosage
  • Male
  • Animal Feed
  • Female
  • Diet / veterinary
  • Cytokines / metabolism

Conflict of Interest Statement

Declaration of competing interest The authors have no conflicts of interest to declare.

Citations

This article has been cited 0 times.